Injections of Rebaian (generic name is iloyumab injection) can not stop the use of statins, and can not simply replace statins, need to be directed by a professional doctor according to the actual condition of the patient’s treatment. Eloxacinumab injection, in addition to its lipid-lowering effect, also has a stabilizing effect on plaque, inflammation and oxidation. It is used for the treatment of primary hypercholesterolemia and mixed dyslipidemia in adults. It mainly targets human preprotein convertase and can be used in combination with other lipid-lowering drugs to treat patients with pure subtype familial hypercholesterolemia and mixed dyslipidemia. Statins lower total cholesterol in the blood mainly by raising LDL, which serves to lower blood lipids. Statins used in patients with acute coronary syndrome can not only lower total cholesterol levels, but also assist in the treatment of atherosclerosis, prevent the development of atherosclerosis, and have the effect of stabilizing plaque, anti-inflammatory and antioxidant. The main side effects of Eloxacinumab Injection are gastrointestinal symptoms such as abdominal distension, diarrhea, abnormalities in liver and kidney function, some of which appear as skin rash and itchy skin. It is contraindicated for those who are allergic to the product. Combine with the characteristics of the patient’s own disease, under the guidance of the doctor to choose the appropriate treatment program.